[EN] FGFR2 MODULATORS<br/>[FR] MODULATEURS DE FGFR2
申请人:EXELIXIS INC
公开号:WO2012061337A1
公开(公告)日:2012-05-10
A compound of Formula (I), or a pharmaceutically acceptable salt thereof, wherein:R3a, R2, R3b, R4b, L1, G and J are as defined in the specification, pharmaceutical compositionsthereof, and methods of use thereof.